ArticleCancers2022

Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.

Julie Egea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.